# Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2

> **NCT02777593** · NA · ACTIVE_NOT_RECRUITING · sponsor: **W.L.Gore & Associates** · enrollment: 250 (actual)

## Conditions studied

- Aortic Aneurysm, Thoracic
- Aorta; Lesion

## Interventions

- **DEVICE:** GORE® TAG® Thoracic Branch Endoprosthesis

## Key facts

- **NCT ID:** NCT02777593
- **Lead sponsor:** W.L.Gore & Associates
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-09-06
- **Primary completion:** 2021-04-12
- **Final completion:** 2027-12
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02777593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02777593, "Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT02777593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*